Brief: Compass Therapeutics Inc Ended Q1 With $175 Million In Cash And Marketable Securities
04/05/2023 13:34
May 4 (Reuters) - Compass Therapeutics Inc. CMPX.O :
* COMPASS THERAPEUTICS INC. - ENDED Q1 WITH $175 MILLION IN
CASH
AND MARKETABLE SECURITIES, PROVIDING CASH RUNWAY FOR COMPANY
INTO 2026
* COMPASS THERAPEUTICS INC.- QTRLY LOSS PER SHARE $0.06
* COMPASS THERAPEUTICS INC. - APPOINTED RICHARD LINDAHL,
M.B.A.,
EVP & CFO OF EMERGENT BIOSOLUTIONS, TO COMPASS BOARD
Source text for Eikon: ID:nGNX8T8wMn
Further company coverage: CMPX.O
Recent news on Compass Therapeutics
See all newsBrief: Compass Announces Inducement Grants Under Nasdaq Listing Rule
US RESEARCH ROUNDUP- Allstate, Autozone, Vertex Pharmaceuticals
U.S. STOCKS ON THE MOVE-Greenland Mines, GameStop, Shopify
U.S. STOCKS ON THE MOVE-Vicor, Thor Industries, Lennar
Brief: Compass Therapeutics Provides Regulatory Update On Tovecimig In Biliary Tract Cancer Following FDA Feedback